Tevogen Bio Inc.
TVGN | NASDAQ
$5.66
-$0.39 (-6.45%)
At close: Oct 30, 2026, 3:59 PM ET
$5.90
+$0.24 (+4.24%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 60.14K | 59.05K | 85.79K | n/a | n/a | n/a | 103.55K | 101.74K | 99.99K | 98.3K | 100.87K | 93.58K | 92.7K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -60.14K | -59.05K | -85.79K | n/a | n/a | n/a | -103.55K | -101.74K | -99.99K | -98.3K | -100.87K | -93.58K | -92.7K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -5.66M | -5.4M | -4.61M | -5.73M | -5.44M | -10.36M | -9.36M | -6.09M | -8.6M | -29.52M | -2.01M | -2.33M | -2.18M | -2.32M | -212.79K | -198.83K | -258.59K | -282.88K | -170.01K | -115 | -11.3K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6 | n/a | 632.8K | n/a | n/a | n/a | 2.74M | 1.74M | 327.83K | 140.89K | 15.81K | n/a | n/a |
Pretax Income | -5.76M | -5.45M | -4.68M | -5.73M | -5.5M | -10.37M | -9.44M | -5.88M | -9.66M | 11.26M | -3.63M | -3.9M | -22.18M | -30.76M | 2.61M | 1.61M | 207K | -25.99K | -17.33K | -115 | -11.3K |
Net Income | -5.76M | -5.45M | -4.68M | -5.73M | -5.5M | -10.37M | -9.25M | -5.91M | -6.05M | 11.26M | -3.63M | -3.9M | -22.18M | -30.76M | 2.61M | 1.61M | 207K | -25.99K | -17.33K | -115 | -11.3K |
Selling & General & Admin | 2.38M | 2.27M | 2.5M | 2.62M | 2.74M | 7.16M | 6.42M | 2.72M | 4.37M | 8.71M | 1M | 1.11M | 1.06M | 977.11K | 212.79K | 198.83K | 258.59K | 282.88K | 170.01K | 115 | 11.3K |
Research & Development | 3.28M | 3.13M | 2.11M | 3.11M | 2.7M | 3.2M | 2.84M | 3.26M | 4.12M | 20.81M | 908.05K | 1.12M | 1.03M | 1.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -60.14K | -59.05K | -85.79K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 5.6M | 5.34M | 4.52M | 5.73M | 5.44M | 10.36M | 9.26M | 5.98M | 8.5M | 29.42M | 1.91M | 2.23M | 2.09M | 2.32M | 212.79K | 198.83K | 258.59K | 282.88K | 170.01K | 115 | 11.3K |
Interest Expense | 98.39K | -71.17K | 70.67K | 62.34K | 38.03K | 24.57K | 15.8K | 12.46K | n/a | 155.79K | n/a | 299.94K | 299.89K | 289K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.66M | 5.4M | 4.61M | 5.73M | 5.44M | 10.36M | 9.36M | 6.09M | 8.6M | 29.52M | 2.01M | 2.33M | 2.18M | 2.32M | 212.79K | 198.83K | 258.59K | 282.88K | 170.01K | 115 | 11.3K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.83M | 3.49M | 3.32M | 3.92M | 3.69M | 3.23M | 3.56M | 3.4M | 3.08M | 2.75M | 3.24M | 3.16M | 2.78M | 2.4M | 958.67K | 958.67K | 958.67K | 958.67K | 958.67K | 929.67K | 929.67K |
Shares Outstanding (Diluted) | 3.83M | 3.49M | 3.32M | 3.92M | 3.69M | 3.23M | 3.56M | 3.4M | 3.08M | 2.85M | 3.24M | 3.16M | 2.78M | 2.4M | 958.67K | 958.67K | 958.67K | 958.67K | 958.67K | 929.67K | 929.67K |
EPS (Basic) | -1.52 | -1.61 | -1.20 | -1.50 | -1.53 | -3.25 | -2.60 | -1.74 | -1.97 | 4 | -0.26 | -1.24 | -8 | -13 | 2.73 | 1.68 | 0.21 | -0.03 | -0.02 | 0 | -0.01 |
EPS (Diluted) | -1.52 | -1.61 | -1.20 | -1.50 | -1.53 | -3.25 | -2.60 | -1.74 | -1.97 | -13 | -0.26 | -1.24 | -8 | -13 | 2.73 | 1.68 | 0.21 | -0.03 | -0.02 | 0 | -0.01 |
EBITDA | -5.6M | -5.46M | -4.52M | -5.37M | -5.48M | -10.24M | -9.33M | -5.77M | -9.56M | 11.52M | -3.21M | -3.51M | -21.79M | -30.38M | 2.81M | 1.61M | 207K | -25.99K | -17.33K | -115 | -11.3K |
EBIT | -5.66M | -5.52M | -4.61M | -5.66M | -5.5M | -10.34M | -9.43M | -5.87M | -9.66M | 11.42M | -3.31M | -3.61M | -21.88M | -30.47M | 2.61M | 1.61M | 207K | -25.99K | -17.33K | -115 | -11.3K |
Depreciation & Amortization | 60.14K | 59.05K | 85.79K | 291.42K | 26.59K | 105.4K | 103.55K | 101.74K | 99.99K | 98.3K | 100.87K | 93.58K | 92.7K | 91.21K | 196.06K | 2.1K | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove TVGN